Press Releases

January 09, 2017
Moderna Provides Pipeline and Full-Year Corporate Update
January 04, 2017
Moderna Joins the Human Vaccines Project to Help Advance Fundamental Understanding of the Immune System
January 03, 2017
Moderna to Highlight its mRNA Development Candidate Pipeline at 2017 J.P. Morgan Healthcare Conference
October 27, 2016
Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine
October 06, 2016
Moderna Appoints Annie Seibold Drapeau as Chief Human Resources Officer
September 21, 2016
Moderna to Build State-of-the-Art Fully Integrated GMP mRNA Clinical Manufacturing Facility in Norwood, Mass.
September 13, 2016
Moderna Appoints Melissa J. Moore, Ph.D., as Chief Scientific Officer of Moderna’s mRNA Research Platform
September 07, 2016
Moderna Enters New Growth Phase with Closing of $474 Million Equity Financing and its First BARDA Grant for up to $125 Million for Zika mRNA Vaccine
September 07, 2016
Moderna Announces Funding Award from BARDA for $8 Million with Potential of up to $125 Million to Accelerate Development of Zika Messenger RNA (mRNA) Vaccine
July 26, 2016
Moderna Therapeutics Provides Mid-Year Corporate Update, Announces Continued Clinical Development Progress and Pipeline Acceleration

Media Coverage

Boston Globe
November 17, 2016
Top Places to Work: Top Large Employers
October 28, 2016
Science Top Employer 2016 – Top firms bring out creativity, growth in their scientists
September 21, 2016
Biotech unicorn Moderna gambles $110M on a groundbreaking mRNA manufacturing facility, blueprints plant #2
Boston Globe
September 21, 2016
Moderna bets big with $110 million drug plant in Norwood
September 21, 2016
Moderna lays out ambitious $110M facility for clinical supplies
Boston Business Journal
September 21, 2016
Moderna plans more than 100 new hires at new Norwood manufacturing site
BioPharm International
September 21, 2016
Moderna Therapeutics Plans mRNA Clinical Manufacturing Facility
Boston Globe
September 07, 2016
Cambridge biotech firm Moderna wins Zika vaccine grant
September 07, 2016
Moderna gains BARDA Zika vax funding; closes $474M funding round
September 07, 2016
Moderna Wins Up to $125M from BARDA toward Zika mRNA Vaccine